Medicinal plants

Full-Spectrum Seed-to-Sale Model, Quality Branding Key to Cannabis Success

Retrieved on: 
Wednesday, May 8, 2019
Cannabis smoking, Entheogens, Euphoriants, Herbalism, Medicinal plants, Cannabis, Forward-looking statement, Navistar International, Human behavior, Medicine, Humans

TransCanna is intent on ensuring maximum brand consistency by handling every aspect of the production process from procurement and branding and design through to distribution, transportation, marketing and sales.

Key Points: 
  • TransCanna is intent on ensuring maximum brand consistency by handling every aspect of the production process from procurement and branding and design through to distribution, transportation, marketing and sales.
  • Total revenues from the acquisition, including manufacturing, extraction, distribution and cannabis sales, are currently projected to be from $220 million to $363 million a year.
  • This massive deal could make Canopy a real juggernaut, with a leading position in every major international market for legal cannabis.
  • You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.

True Farma Launches Full Spectrum Hemp-Derived Cannabidiol (CBD) Online Store with Delivery to All 50 States

Retrieved on: 
Wednesday, May 8, 2019
Medicinal plants, Medicine, Health sciences, Health, Herbalism, Entheogens, Euphoriants, Herbs, Cannabis, Medical cannabis, FARMA, Hemp

The company's site ( www.TrueFarmaCBD.com ) offers CBD products available for delivery across the U.S. to adults 18 and over.

Key Points: 
  • The company's site ( www.TrueFarmaCBD.com ) offers CBD products available for delivery across the U.S. to adults 18 and over.
  • True Farma carries only products that pass strict laboratory testing and are backed by documented proof of testing.
  • "True Farma is leading the way for better access to lab-tested, dose-specific, hemp-derived CBD products.
  • True Farma carefully screens its many manufacturer partners' products, and is focused on providing easy access to lab-tested, dose-specific, medical cannabis and full-spectrum, hemp-derived CBD products.

DeepSixCBD.com Goes Live! Opens Sixth CBD Store in Bensalem, PA

Retrieved on: 
Wednesday, May 8, 2019
Herbs, Entheogens, Euphoriants, Medicinal plants, Drugs, Plants, Organ systems, Cannabidiol, Resorcinols, Hemp, Cannabis, Neshaminy

The addition of a new Deep Six store to the Neshaminy Mall in Bensalem, PA reflects the impact that CBD products have had on the legal hemp and cannabis markets.

Key Points: 
  • The addition of a new Deep Six store to the Neshaminy Mall in Bensalem, PA reflects the impact that CBD products have had on the legal hemp and cannabis markets.
  • The revised Farm Bill of 2018 and its new approach to hemp-derived products has created new opportunities for the production and sale of CBD products in the retail sector.
  • Partnering with a curated list of premium CBD suppliers helped us to rise to the challenge of our business' growth.
  • For those in the know, CBD oil, CBD edibles, and CBD vape have become a self-treatment mainstay.

Legalized Cannabis Market to Clock Revenue of US$ 81.4 Bn by 2027, Surging Demand for Cannabis Herb Provides Growth Impetus - TMR

Retrieved on: 
Wednesday, May 8, 2019
Medicine, Herbalism, Medicinal plants, Cannabis smoking, Health sciences, Health, Cannabis, Entheogens, Medical cannabis, Effects of cannabis

These popular companies in the global legalized cannabis market are mainly targeting to acquire strategies such as mergers and acquisitions.

Key Points: 
  • These popular companies in the global legalized cannabis market are mainly targeting to acquire strategies such as mergers and acquisitions.
  • Request a Sample of Global Legalized Cannabis Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_...
    TMR's experts reveal that the growth in the global legalized cannabis market is projected to occur at a meteoric CAGR of 17.2% during the assessment tenure 2018-2027.
  • Along with this, several sensory appealing characteristics of cannabis is also fueling demand in the global legalized cannabis market.
  • Thus, soaring demand for the effective skin treatment and rapidly growing personal care industry are also fueling growth in the global legalized cannabis market.

Legalized Cannabis Market to Clock Revenue of US$ 81.4 Bn by 2027, Surging Demand for Cannabis Herb Provides Growth Impetus - TMR

Retrieved on: 
Wednesday, May 8, 2019
Medicine, Herbalism, Medicinal plants, Cannabis smoking, Health sciences, Health, Cannabis, Entheogens, Medical cannabis, Effects of cannabis

These popular companies in the global legalized cannabis market are mainly targeting to acquire strategies such as mergers and acquisitions.

Key Points: 
  • These popular companies in the global legalized cannabis market are mainly targeting to acquire strategies such as mergers and acquisitions.
  • Request a Sample of Global Legalized Cannabis Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_...
    TMR's experts reveal that the growth in the global legalized cannabis market is projected to occur at a meteoric CAGR of 17.2% during the assessment tenure 2018-2027.
  • Along with this, several sensory appealing characteristics of cannabis is also fueling demand in the global legalized cannabis market.
  • Thus, soaring demand for the effective skin treatment and rapidly growing personal care industry are also fueling growth in the global legalized cannabis market.

Growpacker Inc. Launches Proprietary Infusion and Emulsification Technology for THC and CBD Consumer Product Manufacturing

Retrieved on: 
Tuesday, May 7, 2019
Health, Other Health, Manufacturing, Other Manufacturing, Natural Resources, Other Natural Resources, Retail, Food, Beverage, Specialty, Other Retail, Medicine, Euphoriants, Appetite stimulants, Entheogens, Herbalism, Medicinal plants, Drugs, Psychoactive drugs, Cannabis, Hemp, Tetrahydrocannabinol, Medical cannabis

Growpacker Inc. ("Growpacker" or the "Company"), a contract manufacturer of THC and CBD-infused edibles and beverages in the United States, has announced the launch of a proprietary technology used for the emulsification and infusion of THC and/or CBD distillate.

Key Points: 
  • Growpacker Inc. ("Growpacker" or the "Company"), a contract manufacturer of THC and CBD-infused edibles and beverages in the United States, has announced the launch of a proprietary technology used for the emulsification and infusion of THC and/or CBD distillate.
  • Growpacker has been rapidly and consistently adding to its portfolio of problem-solving IP for cannabis and CBD companies, and this new emulsification and infusion technology streamlines the manufacturing process even further, said Stephen Boyd, CEO of Growpacker.
  • Our commitment to innovation is a top priority and we will continue to be a technology and science driven-cannabis company."
  • Growpacker will be offering the new technology as part of its core manufacturing process.

Activist Soapmaker David Bronner Partners with Flow Kana to Launch Ethically and Ecologically Sourced Cannabis Brand

Retrieved on: 
Tuesday, May 7, 2019
Entheogens, Euphoriants, Medicinal plants, Herbs, Plants, Agronomy, Cannabis cultivation, Cannabis, Hemp, Bronner, Organic farming, Agriculture

Brother David's is a social venture founded by cannabis and organic advocate, and activist soapmaker David Bronner, powered by small sun-grown farmer champion and sustainable cannabis supply chain company Flow Kana, to promote Sun + Earth certified cannabis and support small-scale organic cannabis farmers.

Key Points: 
  • Brother David's is a social venture founded by cannabis and organic advocate, and activist soapmaker David Bronner, powered by small sun-grown farmer champion and sustainable cannabis supply chain company Flow Kana, to promote Sun + Earth certified cannabis and support small-scale organic cannabis farmers.
  • To learn more, please visit: brotherdavids.com
    All Brother David's cannabis products are third party certified under the new Sun + Earth Certification, an ethical and ecological certification program for cannabis producers.
  • Now, we need to advance consumer and environmental interests by implementing regenerative organic agriculture in the cannabis industry," said Brother David's founder, David Bronner.
  • Flow Kana worked closely with Brother David's to select the finest cannabis grown on Earth in ideal living soil conditions.

Canopy Growth Introduces Spectrum Therapeutics

Retrieved on: 
Tuesday, May 7, 2019
Health, Medicine, Antiemetics, Entheogens, Euphoriants, Medicinal plants, Canopy Growth, Beckley Foundation, Dronabinol, Cannabinoid, Medical cannabis, Effects of cannabis

SMITHS FALLS, Ontario, May 7, 2019 /PRNewswire/ --Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) is pleased to introduce Spectrum Therapeutics, a new global brand that will encompass all of the Company's ongoing medical and research operations including Spectrum Cannabis, Canopy Health Innovations (CHI), and the most recent addition to Canopy Growth's medical portfolio, Bionorica SE-founded C3 Cannabinoid Compound Company ("C3"), a European leader in cannabinoid-based medical therapies.

Key Points: 
  • SMITHS FALLS, Ontario, May 7, 2019 /PRNewswire/ --Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) is pleased to introduce Spectrum Therapeutics, a new global brand that will encompass all of the Company's ongoing medical and research operations including Spectrum Cannabis, Canopy Health Innovations (CHI), and the most recent addition to Canopy Growth's medical portfolio, Bionorica SE-founded C3 Cannabinoid Compound Company ("C3"), a European leader in cannabinoid-based medical therapies.
  • Dronabinol, while integrated into the Spectrum Therapeutics' commercial offering, will continue to be marketed under C3's brand, Bionorica Ethics.
  • All Spectrum Cannabis branding include the various web properties will be transitioned to the new Spectrum Therapeutics identity over the coming months.
  • Canopy Growth works with the Beckley Foundation and has launched Beckley Canopy Therapeutics to research and develop clinically validated cannabis-based medicines, with a strong focus on intellectual property protection.

Canopy Growth Introduces Spectrum Therapeutics

Retrieved on: 
Tuesday, May 7, 2019
Health, Medicine, Antiemetics, Entheogens, Euphoriants, Medicinal plants, Canopy Growth, Beckley Foundation, Dronabinol, Cannabinoid, Medical cannabis, Effects of cannabis

SMITHS FALLS, Ontario, May 7, 2019 /PRNewswire/ --Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) is pleased to introduce Spectrum Therapeutics, a new global brand that will encompass all of the Company's ongoing medical and research operations including Spectrum Cannabis, Canopy Health Innovations (CHI), and the most recent addition to Canopy Growth's medical portfolio, Bionorica SE-founded C3 Cannabinoid Compound Company ("C3"), a European leader in cannabinoid-based medical therapies.

Key Points: 
  • SMITHS FALLS, Ontario, May 7, 2019 /PRNewswire/ --Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) is pleased to introduce Spectrum Therapeutics, a new global brand that will encompass all of the Company's ongoing medical and research operations including Spectrum Cannabis, Canopy Health Innovations (CHI), and the most recent addition to Canopy Growth's medical portfolio, Bionorica SE-founded C3 Cannabinoid Compound Company ("C3"), a European leader in cannabinoid-based medical therapies.
  • Dronabinol, while integrated into the Spectrum Therapeutics' commercial offering, will continue to be marketed under C3's brand, Bionorica Ethics.
  • All Spectrum Cannabis branding include the various web properties will be transitioned to the new Spectrum Therapeutics identity over the coming months.
  • Canopy Growth works with the Beckley Foundation and has launched Beckley Canopy Therapeutics to research and develop clinically validated cannabis-based medicines, with a strong focus on intellectual property protection.

Euromonitor Reveals Top 15 Most Attractive Markets for Legal Cannabis

Retrieved on: 
Tuesday, May 7, 2019
Other Consumer, Health, Other Health, Natural Resources, Agriculture, Retail, Communications, Marketing, Tobacco, Wine & Spirits, Other Retail, Consumer, Medicinal plants, Medicine, Herbalism, Entheogens, Euphoriants, Cannabis smoking, Health sciences, Health, Cannabis, Legality of cannabis, Medical cannabis, Effects of cannabis

Global market research company Euromonitor International identifies the top 15 countries with the most market potential for legal cannabis in a new white paper , The Cannabis Index: Where Will Legalisation Move Next?.

Key Points: 
  • Global market research company Euromonitor International identifies the top 15 countries with the most market potential for legal cannabis in a new white paper , The Cannabis Index: Where Will Legalisation Move Next?.
  • Canada takes the top spot on the Euromonitor Cannabis Legalisation Index followed by the U.S., Italy, Uruguay and Germany, respectively.
  • The high recreational use of illegal cannabis and legal low-THC products make the country an attractive market for legal cannabis.
  • The new Euromonitor Cannabis Legalisation Index ranks 100 countries on market potential for legal cannabis, using three indicators to score attractiveness: legal status, socio-demographics and current consumption of tobacco, alcohol and cannabis.